Ascendis Pharma A/S has announced its strategic roadmap and key milestones for 2025, highlighting their potential for rapid revenue growth linked to the launch of their first two Endocrinology Rare ...
CALGARY, AB, Dec. 23, 2025 /PRNewswire/ - High Tide Inc. (HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback